# EDGAR Filing Document

**Accession Number:** 0001108205
**File Stem:** 0000000000-26-001698
**Filing Date:** 2026-2
**Character Count:** 2222
**Document Hash:** ee5b9164a0db56c5389e8cac7560b65c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-001698.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0000000000-26-001698

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260219

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CURIS INC
- **CENTRAL INDEX KEY:** 0001108205
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 043505116
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-293470

**BUSINESS ADDRESS:**
- **STREET 1:** 128 SPRING STREET
- **STREET 2:** BUILDING C, SUITE 500
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421
- **BUSINESS PHONE:** 617-503-6500

**MAIL ADDRESS:**
- **STREET 1:** 128 SPRING STREET
- **STREET 2:** BUILDING C, SUITE 500
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001108205-26-000009

## Text-Extract

```

                                                           February 19, 2026

James E. Dentzer
Chief Executive Officer
Curis, Inc.
128 Spring Street, Building C Suite 500
Lexington, MA 02421

       Re: Curis, Inc.
           Registration Statement on Form S-3
           Filed February 13, 2026
           File No. 333-293470
Dear James E. Dentzer:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Doris Stacey Gama at 202-551-3188 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Caroline Dotolo, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._